2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of…

• BA
  Brigham and Women's Hospital
• HY
  Helsingin Yliopisto
• QM
  Queen Mary University of London
• DZ
  Deutsches Zentrum für Herz-Kreislaufforschung
• UD
  Università degli Studi di Milano
• IU
  Inselspital, Universitätsspital Bern
• NI
  National Institute for Health and Care Research
• UO
  University of Oxford
• IN
  Institut National de la Santé et de la Recherche Médicale
• UL
  Universiteit Leiden
• UG
  Universiteit Gent
• LU
  Leids Universitair Medisch Centrum
• HÜ
  Hacettepe Üniversitesi
• GU
  Göteborgs Universitet
• BI
  Berlin Institute of Health
• SU
  Sorbonne Université
• MR
  Medical Research Council

  Award: MC_UU_00017/4
• BA
  Barts and The London School of Medicine and Dentistry
• SA
  Sahlgrenska Akademin
• NO
  NIHR Oxford Biomedical Research Centre
• FO
  Faculty of Medicine and Health, University of Sydney